Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingping Su

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|June 8, 2004
Demonstration of a universal surface DNA computerXingping Su, Lloyd M Smith
European Journal of Medicinal Chemistry|July 27, 2021
Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectivesLin Yue, Yaojie Shi, Xingping Su, et al.
Journal of Medicinal Chemistry|March 20, 2023
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future PerspectivesYuting Xie, Lin Yue, Yaojie Shi, et al.
RSC Advances|April 28, 2022
Design, synthesis and biological evaluation of 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine derivatives as potent fibroblast growth factor receptor inhibitorsXingping Su, Zhihao Liu, Lin Yue, et al.
European Journal of Medicinal Chemistry|June 26, 2025
Focal adhesion kinase inhibitors in fibrotic diseases therapy: Development and therapeutic potentialCailing Gan, Wei Wei, Taixiong Xue, et al.
European Journal of Medicinal Chemistry|August 29, 2022
Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agentsLin Yue, Taixiong Xue, Xingping Su, et al.
European Journal of Medicinal Chemistry|November 19, 2022
Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosisXingping Su, Zui Tan, Guan Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2022
An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF-β1 signallingTaixiong Xue, Lin Yue, Guonian Zhu, et al.
European Journal of Medicinal Chemistry|December 4, 2022
Discovery of the novel Benzo[b]thiophene 1,1-dioxide derivatives as a potent STAT3 inhibitor against idiopathic pulmonary fibrosisYijie Wang, Hongyao Liu, Wenzhen Li, et al.
European Journal of Medicinal Chemistry|March 26, 2025
Design, synthesis and biological evaluation of 3-amino-6-(2-hydroxyphenyl)pyridazin-4-aryl derivatives as SMARCA2/4 degradersTianqiong Yang, Wei Wei, Qi Zhang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|June 8, 2004
Demonstration of a universal surface DNA computerXingping Su, Lloyd M Smith
European Journal of Medicinal Chemistry|July 27, 2021
Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectivesLin Yue, Yaojie Shi, Xingping Su, et al.
Journal of Medicinal Chemistry|March 20, 2023
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future PerspectivesYuting Xie, Lin Yue, Yaojie Shi, et al.
RSC Advances|April 28, 2022
Design, synthesis and biological evaluation of 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine derivatives as potent fibroblast growth factor receptor inhibitorsXingping Su, Zhihao Liu, Lin Yue, et al.
European Journal of Medicinal Chemistry|June 26, 2025
Focal adhesion kinase inhibitors in fibrotic diseases therapy: Development and therapeutic potentialCailing Gan, Wei Wei, Taixiong Xue, et al.
European Journal of Medicinal Chemistry|August 29, 2022
Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agentsLin Yue, Taixiong Xue, Xingping Su, et al.
European Journal of Medicinal Chemistry|November 19, 2022
Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosisXingping Su, Zui Tan, Guan Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2022
An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF-β1 signallingTaixiong Xue, Lin Yue, Guonian Zhu, et al.
European Journal of Medicinal Chemistry|December 4, 2022
Discovery of the novel Benzo[b]thiophene 1,1-dioxide derivatives as a potent STAT3 inhibitor against idiopathic pulmonary fibrosisYijie Wang, Hongyao Liu, Wenzhen Li, et al.
European Journal of Medicinal Chemistry|March 26, 2025
Design, synthesis and biological evaluation of 3-amino-6-(2-hydroxyphenyl)pyridazin-4-aryl derivatives as SMARCA2/4 degradersTianqiong Yang, Wei Wei, Qi Zhang, et al.
Pageof 2